Live from the NIH registry
Studies recruiting near Detroit right now
Top 25 of 1,197 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Ypsilanti, Michigan (27.9 mi)
· Sponsor: Medtronic
Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)
Tennis Elbow, Lateral Epicondylitis
Phase 4
Interventional 40 participants sought
Henry Ford Hospital — Detroit, Michigan (4.6 mi)
· Sponsor: Henry Ford Health System
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Henry Ford Health — Detroit, Michigan (4.6 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Henry Ford Health System — Detroit, Michigan (4.6 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Barbara Ann Karmanos Cancer Institute — Detroit, Michigan (4.6 mi)
· Sponsor: Syndax Pharmaceuticals
Emsella Chair vs Sham for Male Sexual Dysfunction
Male Sexual Dysfunction, Ejaculatory Dysfunction
N/A
Interventional 117 participants sought
Corewell Health William Beaumont University Hospital — Royal Oak, Michigan (7.6 mi)
· Sponsor: Corewell Health East
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Oakland Ophthalmic Surgery — Birmingham, Michigan (12.6 mi)
· Sponsor: VisionCare, Inc.
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Large Cell Lymphoma, Diffuse, Relapsed Cancer
Phase 2
Interventional 35 participants sought
Karmanos Cancer Center (Wayne State University) — Detroit, Michigan (4.6 mi)
· Sponsor: Dipenkumar Modi
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Michigan — Detroit, Michigan (4.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Karmanos Cancer Institute — Detroit, Michigan (4.6 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Henry Ford Health System — Detroit, Michigan (4.6 mi)
· Sponsor: Hoffmann-La Roche
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Detroit, MI — Detroit, Michigan (4.6 mi)
· Sponsor: Mediar Therapeutics
A Study of the TheraBionic P1 Device in Breast Cancer
Breast Cancer Stage I, Breast Cancer Stage II
N/A
Interventional 24 participants sought
Karmanos Cancer Institute — Detroit, Michigan (4.6 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Allen Park — Allen Park, Michigan (10.3 mi)
· Sponsor: Tectonic Operating Company, Inc.
Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty
Osteoarthritis (OA) of the Knee
Phase 4
Interventional 150 participants sought
Henry Ford Medical Center - Grosse Pointe Cottage — Grosse Pointe Farms, Michigan (10.9 mi)
· Sponsor: Henry Ford Health System
Study of SGN1 in Patients With Advanced Solid Tumor
Advanced Solid Tumor
Phase 1, Phase 2
Interventional 70 participants sought
Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center — Detroit, Michigan (4.6 mi)
· Sponsor: Guangzhou Sinogen Pharmaceutical Co., Ltd
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Parkinson's Disease
Phase 1
Interventional 124 participants sought
Quest Research Institute - Alcanza — Farmington Hills, Michigan (15.7 mi)
· Sponsor: Prevail Therapeutics
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Aortic Stenosis Treated With TAVI, Aortic Diseases
N/A
Interventional 500 participants sought
Henry Ford Hospital — Detroit, Michigan (4.6 mi)
· Sponsor: EnCompass Technologies, Inc.
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Wayne State University - Detroit Medical Center — Detroit, Michigan (4.6 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Wayne State University School of Medicine — Detroit, Michigan (4.6 mi)
· Sponsor: Kura Oncology, Inc.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) — Detroit, Michigan (4.6 mi)
· Sponsor: Pfizer
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Detroit, Michigan (4.6 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Karmanos Cancer Institute — Detroit, Michigan (4.6 mi)
· Sponsor: Eli Lilly and Company
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Wayne State University — Detroit, Michigan (4.6 mi)
· Sponsor: Takeda
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Secondary Progressive Multiple Sclerosis
Phase 3
Interventional 990 participants sought
Profound Research LLC at Oakland Neurology Center — Rochester Hills, Michigan (19.2 mi)
· Sponsor: Zenas BioPharma (USA), LLC